ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Antithymocytes Globulines and Immune Senescence in Renal Transplant Patients

    J. Bamoulid, C. Roubiou, T. Crépin, B. Gaugler, P. Tiberghien, C. Ferrand, J. Chalopin, P. Saas, D. Ducloux

    Nephrology, CHU Besançon, Besançon, France; UMR 1098, INSERM, Besançon, France; Plateforme de Biomonitoring CIC-BT506, EFS Bourgogne Franche-Comté, Besançon, France

    Background: CD4 T cell reconstitution after antithymocytes globulins (ATG) is dependent on pre-transplant thymic function and persistent ATG-induced CD4 T cell lymphopenia is associated with…
  • 2013 American Transplant Congress

    Recurrence of Focal Segmental Glomerulosclerosis after Renal Transplantation: Who Benefits from Preemptive Plasmapheresis?

    D. Bruley, L. Croze, B. Burroni, N. Pinel, P. Malvezzi, P. Zaoui

    Clinique de Néphrologie et de Transplantation Rénale, Centre Hospitalier Universitaire Michallon, Grenoble, France; Laboratoire d'Anatomie Pathologique, Centre Hospitalier Universitaire Michallon, Grenoble, France

    BACKGROUND: Post-transplant recurrence of primary focal segmental glomerulosclerosis (FSGS) has been attributed to a persistent circulating permeability factor. Prophylactic peri-operative plasmapheresis (PP) has been used…
  • 2013 American Transplant Congress

    Thymic Evidence of Clone Deletion in the Mixed Chimerism Mediated Allograft Tolerance

    W. Zhang, Y. Wang, Y. Yang, V. Gorantla, M. Solari, X. Zheng

    Plastic Surgery, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; East Hospital of Tongji University, Shanghai, China

    Introduction: We have achieved stable mixed chimerism (MC) and tolerance in mice hind-limb transplant model using a non-myeloabative conditioning regimen, and demonstrated that the deletion…
  • 2013 American Transplant Congress

    Continuous Coronary Sinus Perfusion for Recovery of Hearts from Non-Heart-Beating Donors

    M. Peltz, S. Brant, M. Cobert, L. West, M. Jessen

    Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX

    Purpose: DCD donors are not usually considered for heart transplantation. Recent studies suggest that machine perfusion appears promising for improving preservation of donor hearts and…
  • 2013 American Transplant Congress

    Predicting Patient Survival after Kidney Transplantation (KTx): The First Year and Beyond

    A. Muriithi, M. Keddis, E. Rodrigo, M. El Ters, P. Dean, H. Amer, F. Cosio

    Nephrology and Transplantation, Mayo Clinic, Rochester, MN

    Introduction: An important goal of pre-transplant evaluation is to identify candidates at risk for cardiovascular (CV) events and mortality post-transplant. Current approaches for risk assessment…
  • 2013 American Transplant Congress

    With Induction, Donor Age, Recipient Age > 60, Female Gender, and Rejection Hinder Patient Survival after Liver Transplantation for HCV. Donor Age and Rejection Increase Severe Fibrosis, Whereas rATG May Be Protective

    M. Montenovo, J. Brandenberger, R. Bakthavatsalam, J. Haldorson, A. Dick, J. Perkins, L. Yu, C. Landis, I. Liou, R. Bhattacharya, R. Carithers, J. Reyes, S. Rayhill

    University of Washington, Seattle

    As our center uses induction therapy in all OLTX recipients, we sought to examine the risk factors important for survival and fibrosis in OLTX for…
  • 2013 American Transplant Congress

    High Levels of Plasma IL-21 Together with EBV-Specific Cytotoxic T Cells (EBVTc) May Contribute Avoidance to Post-Transplant (Tx) Lymphoroliferative Disorder (PTLD) in Pediatric Kidney Tx Patients (pts) Who Had Persistent EBV Infection (PEBV)

    S. Ge, D. Puliyanda, W. Junji, A. Karasyov, E. Kamil, D. Lovato, R. Monette, S. Vikman, S. Jordan, M. Toyoda

    Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles

    Background: PEBV infection is associated with high risk for development of PTLD. Recent studies report a critical role for IL-21 in sustaining viral-specific Tc activity…
  • 2013 American Transplant Congress

    Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?

    R. Charif, H. De Kort, C. Roufosse, P. Brookes, A. McLean, V. Papalois, N. Hakim, D. Taube, J. Galliford

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom

    ABO incompatible [ABOi] live-donor renal transplantation is a successful and accepted form of treatment for patients with end stage renal failure. Most antibody removal protocols…
  • 2013 American Transplant Congress

    Safety and Efficacy of Peginterferon-α2a Plus Ribavirin Treatment in Renal Transplant Recipients with Chronic Hepatitis C; Prospective Cohort Study

    H. Aleid, F. Sania, D. Musa, K. Almeshari, G. Shoail, A. Madani, K. Bzaizi

    Organ Transplant Center, King Faisal Specialist Hospital, Riyadh, Saudi Arabia; Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Medicine, Riyadh Military Hospital, Riyadh, Saudi Arabia

    Chronic hepatitis C virus (HCV) significantly impacts on the survival of renal transplant (RT) recipients. Interferon (IFN)-based therapy in RT recipients has been associated with…
  • 2013 American Transplant Congress

    Collapsing Glomerulopathy of the Kidney Allograft: Is It Different from Idiopathic Collapsing Glomerulopathy of Native Kidney?

    L. Kamal, T. Muthukumar, D. Dadhania, C. Hartono, D. Serur, M. Suthanthiran, S. Seshan

    Cornell University, NY

    Collapsing Glomerulopathy (CG) is a histological entity characterized by glomerular capillary collapse, wrinkling and retraction of the glomerular basement membrane, and glomerular epithelial cell hypertrophy…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences